Záznam dôkazov metódy

Double-blind adaptive experiment

A double-blind adaptive experiment combines two powerful design features: double-blinding, which conceals treatment assignment from both participants and outcome assessors to prevent bias, and adaptive modification, which allows pre-specified changes to the trial's course — such as sample size re-estimation, allocation ratio shifts, or arm dropping — based on accumulating interim data. The result is a rigorous, bias-protected design that can respond to emerging evidence without compromising inferential validity.

Sources recorded, not reviewed

Zdrojový záznam

Citácie skopírované doslovne zo zdrojového záznamu metódy. Nevyplýva z nich žiadne overenie na úrovni tvrdenia.

Double-Blind Adaptive Experimental Design

Taxonomický záznam metódy · process-pipeline / experimental-design

U.S. Food and Drug Administration. (2019). Adaptive Designs for Clinical Trials of Drugs and Biologics: Guidance for Industry. FDA. · URL
Berry, S. M., Carlin, B. P., Lee, J. J., & Muller, P. (2010). Bayesian Adaptive Methods for Clinical Trials. CRC Press. · ISBN 9781439825488

Otvoriť celú metódu

Spracované tvrdenia

Tvrdenia uložené v registri dôkazov, každé s vlastným hodnotením.

Zatiaľ žiadne spracované tvrdenia

Tento pohľad nevymýšľa hodnotenie tvrdenia, ak register žiadne nemá.

Súvisiace metódy

Vygenerované z grafu metód a zobrazené ako vzťahy navrhnuté strojom – nevyplýva z nich žiadne tvrdenie o dôkaze.

Taxonomic bucketAdaptive Experimentmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketAdaptive Randomized Controlled Trialmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketMulti-arm experimentmachine-suggested · Relational suggestion, not evidence.Used in the same domainRandomized Controlled Trialmachine-suggested · Relational suggestion, not evidence.